Metabolic reprogramming is a prominent cancer hallmark that enables uncontrolled growth, survival, and dissemination of tumor cells. Among the diverse metabolic alterations, dysregulation of arginine metabolism has garnered significant attention due to its profound impact on cancer cells and the